| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 12.639 | 61.014 | 48.284 | 1.731 | 0 | 0 | - | - |
| Total Income - EUR | - | - | 12.683 | 61.014 | 48.284 | 1.731 | 0 | 0 | - | - |
| Total Expenses - EUR | - | - | 9.440 | 38.133 | 30.520 | 20.281 | 0 | 0 | - | - |
| Gross Profit/Loss - EUR | - | - | 3.243 | 22.882 | 17.764 | -18.549 | 0 | 0 | - | - |
| Net Profit/Loss - EUR | - | - | 3.032 | 22.272 | 17.281 | -18.567 | 0 | 0 | - | - |
| Employees | - | - | 1 | 2 | 1 | 1 | 0 | 0 | - | - |
Check the financial reports for the company - Dma-Dme S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 2 | 556 | 2.352 | 2.307 | 2.256 | 2.263 | - | - |
| Current Assets | - | - | 4.588 | 30.073 | 22.649 | 14.486 | 14.165 | -2.286 | - | - |
| Inventories | - | - | 0 | 0 | 5 | 5 | 5 | 5 | - | - |
| Receivables | - | - | 313 | 6.428 | 5.331 | 6.243 | 6.104 | 0 | - | - |
| Cash | - | - | 4.275 | 23.645 | 17.313 | 8.239 | 8.056 | -2.291 | - | - |
| Shareholders Funds | - | - | 3.076 | 25.291 | 18.902 | -24 | -23 | -23 | - | - |
| Social Capital | - | - | 44 | 43 | 42 | 41 | 40 | 41 | - | - |
| Debts | - | - | 1.514 | 5.339 | 6.099 | 16.817 | 16.444 | 0 | - | - |
| Income in Advance | - | - | 0 | 0 | 0 | 0 | 0 | 0 | - | - |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4939 - 4939" | |||||||||
| CAEN Financial Year |
4939
|
|||||||||
Comments - Dma-Dme S.r.l.